Skip to content
Screener

Fulgent Genetics, Inc. FLGT Laboratory Services — Investment Income Interest

Other segment segments

Therapeutic Development
$0

Similar metrics at other companies

Information Services Group logo
IIIFact Based Sourcing Advisory Services — Investment Income Interest
$27K-27.0%
Dillards logo
DDSConstruction — Investment Income Interest
$220K+4.8%
Lifevantage Corporation logo
LFVNReportable — Investment Income Interest
$35K-74.8%
PCS
PCSCPerceptive — Investment Income Interest
$807.09K-13.6%
KRAKacquisition logo
KRAQSingle — Investment Income Interest
$2.05M
Strattec Security logo
STRTReportable — Investment Income Interest
-$879K-66.2%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$526.64M-16.5%
Enterprise value$511.45M-6.7%
P/S1.6×-0.4×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 7:08 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-199065
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Laboratory services
Interest income$8,651$8,018
Interest expense(17)(14)
Therapeutic development
Interest income
Interest expense
Total$8,634$8,004

Item 1. Financial Statements.

FAQ

What is Fulgent Genetics, Inc.'s laboratory services — investment income interest?
Fulgent Genetics, Inc. (FLGT) reported laboratory services — investment income interest of $8.65M in Q1 2026.
How has Fulgent Genetics, Inc.'s laboratory services — investment income interest changed year-over-year?
Fulgent Genetics, Inc.'s laboratory services — investment income interest increased by 7.9% year-over-year, from $8.02M to $8.65M.
What is the long-term trend for Fulgent Genetics, Inc.'s laboratory services — investment income interest?
Over 3 years (2022 to 2025), Fulgent Genetics, Inc.'s laboratory services — investment income interest has grown at a 76.5% compound annual growth rate (CAGR), from $5.62M to $30.92M.
What does laboratory services — investment income interest mean?
This metric represents the interest and investment income generated specifically by the laboratory services segment's cash and cash equivalent holdings. It reflects the segment's ability to earn returns on its idle capital, providing insight into the financial efficiency of the business unit's treasury management.

Ask your AI about Fulgent Genetics, Inc.'s laboratory services — investment income interest.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude